| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2019/03/02 | 09 : 13 | Dow Jones News | Synergy Pharmaceuticals Is Approved to Sell Assets to Bausch Health | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 2019/02/27 | 09 : 07 | Dow Jones News | Bausch Health to Acquire Certain Assets of Synergy Pharmaceuticals Inc. | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 2018/12/18 | 05 : 43 | Dow Jones News | Synergy Pharmaceuticals Up 55% on Trulance Progress in Canada | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 2018/12/13 | 01 : 10 | Dow Jones News | Former Pharma Highflier Appreciates Bathroom Humor -- Overheard | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 2018/12/12 | 22 : 18 | Dow Jones News | Bausch Health to Buy Synergy Pharmaceuticals Out of Bankruptcy for $200 Million--Update | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 2018/12/12 | 21 : 14 | Dow Jones News | Bausch Health Agrees to Buy Synergy Pharmaceuticals for $200 Million | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 2012/01/04 | 06 : 44 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 2012/01/04 | 06 : 15 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 2012/01/04 | 06 : 15 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 2011/12/28 | 06 : 05 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 2011/12/22 | 20 : 01 | Edgar (US Regulatory) | Notice of Effectiveness (EFFECT) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 2011/12/22 | 02 : 18 | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(3) (424B3) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 2011/12/20 | 07 : 04 | Edgar (US Regulatory) | Securities Registration Statement (simplified form) (S-3/A) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 2011/12/17 | 04 : 35 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 2011/12/14 | 06 : 41 | Business Wire | Synergy Pharmaceuticals Announces Full Exercise of Over-Allotment Option by Aegis Capital Corp. | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 2011/12/14 | 01 : 56 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 2011/12/13 | 22 : 00 | PR Newswire (US) | Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior V... | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 2011/12/13 | 17 : 00 | Business Wire | Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. & its Chief Scientific Officer & Senior VP of... | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 2011/12/09 | 06 : 29 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 2011/12/09 | 06 : 29 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 2011/12/09 | 06 : 28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 2011/12/09 | 06 : 27 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 2011/12/09 | 06 : 26 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 2011/12/08 | 00 : 31 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 2011/12/07 | 07 : 00 | Business Wire | Synergy Pharmaceuticals Announces Closing of Public Offering of 1,875,000 Units | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 2011/12/02 | 07 : 17 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 2011/12/02 | 07 : 14 | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(2) (424B2) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 2011/12/01 | 22 : 00 | Business Wire | Synergy Pharmaceuticals Inc. Announces Pricing of Public Offering of 1,875,000 Units, Listing on NASDAQ & Effectiveness of Re... | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |